Clover Health Investments, Corp. (CLOV) Earnings History
Annual and quarterly earnings data from 2018 to 2025
Loading earnings history...
CLOV EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
CLOV Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 18.5% | -4.4% | -4.4% |
| 2024 | 26.6% | -3.3% | -3.1% |
| 2023 | 20.3% | -16.3% | -16.9% |
| 2022 | 9.4% | -26.1% | -31.0% |
| 2021 | -5.4% | -43.3% | -39.9% |
Download Data
Export CLOV earnings history in CSV or JSON format
Free sign-in required to download data
Clover Health Investments, Corp. (CLOV) Earnings Overview
As of May 7, 2026, Clover Health Investments, Corp. (CLOV) reported trailing twelve-month net income of -$57M, reflecting -93.6% year-over-year growth. The company earned $-0.11 per diluted share over the past four quarters, with a net profit margin of -4.4%.
Looking at the long-term picture, CLOV's historical earnings data spans multiple years. The company achieved its highest annual net income of -$43M in fiscal 2024.
Clover Health Investments, Corp. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including HUM ($1.13B net income, 0.9% margin), CVS ($2.93B net income, 0.4% margin), ELV ($5.24B net income, 2.8% margin), CLOV has room to improve margins relative to the peer group. Compare CLOV vs HUM →
CLOV Earnings vs Peers
Earnings metrics vs comparable public companies
CLOV Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$86M | -98.9% | -$86M | $-0.17 | -4.4% | -4.4% |
| 2024 | -$43M | +79.8% | -$46M | $-0.09 | -3.1% | -3.3% |
| 2023 | -$213M | +37.2% | -$205M | $-0.45 | -16.9% | -16.3% |
| 2022 | -$340M | +42.2% | -$287M | $-0.71 | -31.0% | -26.1% |
| 2021 | -$588M | -330.9% | -$637M | $-1.25 | -39.9% | -43.3% |
| 2020 | -$136M | +62.5% | -$93M | $-0.23 | -20.3% | -13.8% |
| 2019 | -$364M | -80.1% | -$183M | $-0.90 | -78.7% | -39.6% |
| 2018 | -$202M | - | -$186M | $-4.81 | -71.9% | -66.1% |
See CLOV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CLOV Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CLOV vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCLOV — Frequently Asked Questions
Quick answers to the most common questions about buying CLOV stock.
Is CLOV growing earnings?
CLOV EPS fell to $-0.11, with earnings declining -93.6%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-57M.
What are CLOV's profit margins?
Clover Health Investments, Corp. net margin is -4.4%, with operating margin at -4.4%. Below-average margins reflect competitive or cost pressures.
How consistent are CLOV's earnings?
CLOV earnings data spans 2018-2025. The declining earnings trend is -93.6% YoY. Historical data enables comparison across business cycles.